Xanadu Quantum Technologies Ltd
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $XNDU in the last 30 days.
See all $XNDU insider activity →Xanadu Quantum Technologies (NASDAQ:XNDU) shares rose 7.63% to $4.86 after announcing a multi-year partnership with GlobalFoundries (NASDAQ:GFS) to manufacture components for quantum computers, shifting from lab-scale to industrial production.
Xanadu Quantum Technologies' shares fell 56.2% in September, with a 27.5% drop on Sept. 22 following the end of its lockup period. Despite this, the company announced collaborations with ASML and AMD, and received an outperform rating with a $16 price target from RBC Capital.
Xanadu Quantum Technologies (XNDU) announced that its COO, Rafal Janik, has set up a plan to sell up to 312,914 Class B shares, starting no earlier than December 29, 2026. The plan, approved by Xanadu, includes restrictions and will terminate by December 31, 2027. Sales will be handled by an independent broker.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning XNDU (Xanadu Quantum Technologies Ltd). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent XNDU coverage spans market movers, financial news and corporate actions.
The partnership signals a move to volume production, likely boosting Xanadu's revenue outlook.
Xanadu Quantum Technologies' shares fell 56.2% in September, with a 27.5% drop on Sept. 22 following the end of its lockup period. Despite this, the company announced collaborations with ASML and AMD, and received an outperform rating with a $16 price target from RBC Capital.
Potential modest dilution and insider selling pressure.
Positive catalyst from new coverage.
Analyst upgrade may lift the stock as investors price in the positive outlook.
AlphAI scores every news story that mentions XNDU with an AI model for sentiment and relevance, and aggregates insider trades from Xanadu Quantum Technologies Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Xanadu Quantum Technologies (NASDAQ:XNDU) shares rose 7.63% to $4.86 after announcing a multi-year partnership with GlobalFoundries (NASDAQ:GFS) to manufacture components for quantum computers, shifting from lab-scale to industrial production.
2 min readXanadu Quantum Technologies' shares fell 56.2% in September, with a 27.5% drop on Sept. 22 following the end of its lockup period. Despite this, the company announced collaborations with ASML and AMD, and received an outperform rating with a $16 price target from RBC Capital.
2 min readXanadu Quantum Technologies (XNDU) announced that its COO, Rafal Janik, has set up a plan to sell up to 312,914 Class B shares, starting no earlier than December 29, 2026. The plan, approved by Xanadu, includes restrictions and will terminate by December 31, 2027. Sales will be handled by an independent broker.
1 min readWall Street analyst research calls on Tuesday included upgrades for Kroger (KR), Netflix (NFLX), and others, while PepsiCo (PEP), Ryder Systems (R), and more were downgraded. Futures traded higher after a rough start to the week, with major indices closing lower. Treasury yields rose, oil prices surged, and gold and crypto markets declined.
2 min readRBC Capital initiated coverage of Xanadu Quantum Technologies (XNDU) with an outperform rating and speculative risk. The stock has fallen 55% since its March IPO via a SPAC merger. Xanadu is a Canadian quantum computing company.
1 min readXanadu (XNDU) and Bluefors partnered on a multimillion-dollar collaboration to develop a cryogenic prototype for utility-scale quantum computing. The goal is to create a modular cooling design that could eliminate the need for traditional cryoplants, improving scalability and economics of quantum data centers. The prototype is still in development.
2 min readXanadu Quantum Technologies (XNDU-T) CEO Christian Weedbrook sold 4.6 million shares, nearly 10% of his stake, for $32.8 million after a lockup period ended. The sale occurred on the same day the stock dropped 21.6%, with further decline to $5.33 on the next trading day. Other major shareholders are now free to sell their shares. Xanadu is a quantum computing company competing for U.S. government funding.
2 min readIonQ (IONQ) rose 12.17% after hours to $45.70 after announcing a real-time quantum error correction decoder. D-Wave (QBTS) and Rigetti (RGTI) also gained, while Xanadu (XNDU) recovered from a 21.57% drop. IonQ also secured a hardware agreement with SDT, Inc. Analysts remain optimistic ahead of the Quantum World Congress.
2 min readJaguar Health (JAGX) surged 1190.64% after FDA fee waivers. IONQ (IONQ) rose 0.57% on quantum computing breakthrough. Viking Therapeutics (VKTX) gained 35.67% on positive trial results. Xanadu Quantum (XNDU) fell 21.57% post-IPO lockup expiry. Grab Holdings (GRAB) climbed 8.93% after executive stock purchases.
3 min readXanadu Quantum Technologies (XNDU) appointed Tara Deakin as Chief People Officer, replacing Rebecca Laramée, who becomes Senior Vice President of Human Resources. Deakin brings extensive experience in global enterprise transformation. Dr. Christian Weedbrook, CEO, sold 4.6M Class B shares for ~C$32.8M, reducing his stake but retaining significant voting power. Xanadu focuses on scaling its quantum computing business.
1 min read
